gvtcx

PHE_Scientific (Bristol and Cambridge) - Blood Borne Viruses (CapEx) Extension

UK Health Security Agency Published 26 Apr 2024 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,384,000
Statuscomplete
Category (CPV) 38000000
Deadline30 Dec 2023
Contract start31 Dec 2023
Contract end31 Dec 2024
Procedureselective
SME suitableYes
OCIDocds-b5fd17-e9f1a2de-fcfd-460d-8434-b7bb5af57bfe

Award

SupplierValueDateStatus
QIAGEN LIMITED £1,384,000 25 Apr 2024 active

description

UK Health Security Agency (UKHSA) has extended C50936 (previously ecm_6308) - PHE_Scientific (Bristol and Cambridge) - Blood Borne Viruses (CapEx) by one year and increased the contract value from £1,334,000.00 to £1,384,000.00.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
26 Apr 2024 Award (award) · 10e0966e-fdbb-40b3-9bc5-74669cfc92fa-745274

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.